相关实验视频
Updated: Jun 20, 2026

06:30
Bioassays for Monitoring Insecticide Resistance
Published on: December 30, 2010
33.9K
在喀麦隆的Anopheles funestus中,表征着铁甲状腺耐药性的升级及其对床疗效及其对床疗效的影响,以及分子基础
Hervé Raoul Tazokong1,2, Stevia Ntadoun Tchamga3,4, Magellan Tchouakui3
1Medical Entomology Department, Centre for Research in Infectious Diseases (CRID), Yaoundé, Cameroon. raoul.tazokong@crid-cam.net.
Malaria journal
|October 1, 2025
概括
在喀麦隆,Anopheles funestus蚊子的甲甲酸耐药性正在升级,使得只有甲甲酸的网无效. 这项研究确定了关键的遗传标记物和过度表达的基因,这些基因有助于杀虫剂耐药性,这对于开发新的载体控制策略至关重要.
科学领域:
- 昆虫学和寄生虫学
- 分子生物学分子生物学
- 公共卫生 公共卫生
背景情况:
- 疟疾载体控制在很大程度上依赖于杀虫剂,但非洲广泛的甲状腺素耐药性正在降低干预的有效性.
- 在Anopheles funestus蚊子中增加的铁甲状腺耐药性有助于非洲大陆疟疾负担的增加.
- 了解抗杀虫剂耐药性的分子基础对于有效控制疟疾载体至关重要.
研究的目的:
- 在喀麦隆的Anopheles funestus种群中描述铁甲状腺耐药性的程度和分子机制.
- 为了评估仅甲基和基于PBO的床网对抗耐药蚊子种群的有效性.
- 识别与抗虫剂耐药性相关的特定遗传标记物和基因表达模式.
主要方法:
- 在喀麦隆的Anopheles funestus种群中进行了昆虫易感性测试 (WHO管道测试,圆测试).
- 使用PCR和定量PCR的基因分析确定了已知的耐药性标记物和量化基因表达水平.
- 使用Taqman测定和嵌套PCR确定了Plasmodium sporozoite感染率.
主要成果:
- 在所有研究地点观察到高强度的铁甲状腺耐药性,只有铁甲状腺的网的死亡率显著降低.
- 基于piperonyl butoxide (PBO) 的网显示出对抗抗氧化物耐药蚊子的最佳有效性.
- 在喀麦隆南部,L119F-GSTe2等位基因更为普遍,并赋予了对甲基的耐药性. 一些P450基因在耐药蚊子中过度表达.
结论:
- 在喀麦隆,Anopheles funestus中的甲状腺耐药性正在升级,导致只有甲状腺的载体控制工具的无效性.
- 在具有高甲状腺耐药性的地区,PBO协同网络为疟疾载体控制提供了可行的替代方案.
- 特定的遗传标记物和过度表达的基因,如L119F-GSTe2和某些P450s,都与抗虫剂耐药性有关,为未来的控制策略提供了信息.
相关概念视频
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

